Inventor · disambiguated record
Ping Huang
Also filed as: HUANG PING · HUANG PING Y · HUANG PING-YEN
25 granted patents·15 pending applications·335 citations·filing 1991–2024
96Inventor score
Files withSUGEN INC9ABBVIE BIOTHERAPEUTICS INC8CLEAR CREEK BIO INC5UNIV SHANGHAI JIAOTONG3ASCENDO BIOTECHNOLOGY INC2
Top patents by PatentIndex Score
40 records- 0194US9533054B2Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereofUNIV SHANGHAI JIAOTONG·Filed 2014·Granted Jan 3, 2017·42 cites·5 claims
- 0292US10233258B2Bispecific binding proteins that bind CD40 and mesothelinABBVIE BIOTHERAPEUTICS INC·Filed 2018·Granted Mar 19, 2019·16 cites·10 claims
- 0391US7186716B23-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitorsSUGEN INC·Filed 2003·Granted Mar 6, 2007·64 cites·12 claims
- 0490US7186832B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Mar 6, 2007·32 cites·4 claims
- 0589US9260528B2DAC HYP compositions and methodsABBVIE BIOTHERAPEUTICS INC·Filed 2015·Granted Feb 16, 2016·7 cites·8 claims
- 0688US11230528B2Compositions and methods for inhibiting dihydroorotate dehydrogenaseCLEAR CREEK BIO INC·Filed 2020·Granted Jan 25, 2022·2 cites·20 claims
- 0788US9676860B2DAC HYP compositions and methodsABBVIE BIOTHERAPEUTICS INC·Filed 2015·Granted Jun 13, 2017·7 cites·8 claims
- 0888US6596772B1Phosphate mimics and methods of treatment using phosphatase inhibitorsSUGEN INC·Filed 2000·Granted Jul 22, 2003·53 cites·20 claims
- 0987US9815903B2DAC HYP compositionsABBVIE BIOTHERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·5 cites·12 claims
- 1087US9340619B2DAC HYP compositions and methodsABBVIE BIOTHERAPEUTICS INC·Filed 2015·Granted May 17, 2016·6 cites·4 claims
- 1184US6465507B23-(pyrolyllactone)-2-indolinone compounds as kinase inhibitorsSUGEN INC·Filed 2001·Granted Oct 15, 2002·40 cites·15 claims
- 1282US8242129B26-phenylpyrimidinones as PIM modulatorsTSUHAKO AMY L·Filed 2008·Granted Aug 14, 2012·8 cites·12 claims
- 1381US10889548B2Compositions and methods for inhibiting dihydroorotate dehydrogenaseCLEAR CREEK BIO INC·Filed 2019·Granted Jan 12, 2021·2 cites·6 claims
- 1479US12076315B2Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereofCLEAR CREEK BIO INC·Filed 2021·Granted Sep 3, 2024·1 cites·14 claims
- 1579US8324231B2Pyrimidinones as casein kinase II (CK2) modulatorsKOLTUN ELENA S·Filed 2008·Granted Dec 4, 2012·5 cites·10 claims
- 1678US8076338B2Kinase modulators and methods of useANAND NEEL K·Filed 2005·Granted Dec 13, 2011·7 cites·53 claims
- 1777US10463743B2Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereofUNIV SHANGHAI JIAOTONG·Filed 2016·Granted Nov 5, 2019·1 cites·5 claims
- 1877US7157460B2Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitorsSUGEN INC·Filed 2004·Granted Jan 2, 2007·8 cites·4 claims
- 1977US6635640B24-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitorsSUGEN INC·Filed 2001·Granted Oct 21, 2003·10 cites·13 claims
- 2073US7053086B24-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitorsSUGEN INC·Filed 2003·Granted May 30, 2006·6 cites·12 claims
- 2171US12012383B2Compositions and methods for inhibiting dihydroorotate dehydrogenaseCLEAR CREEK BIO INC·Filed 2021·Granted Jun 18, 2024·0 cites·19 claims
- 2269US10960078B2Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereofUNIV SHANGHAI JIAOTONG·Filed 2019·Granted Mar 30, 2021·0 cites·7 claims
- 2369US2020157230A1Dac hyp compositions and methodsABBVIE BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2469US2025248989A1Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereofCLEAR CREEK BIO INC·Filed 2024·Application pending·0 cites
- 2562US2018127506A1Dac hyp compositions and methodsABBVIE BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2657US2012301429A1Dac hyp compositions and methodsHARTMAN TAYMAR E·Filed 2012·Application pending·0 cites
- 2753US2024084017A1Monoclonal antibody against human mac-1 and uses thereofLEE FRANK WEN CHI·Filed 2021·Application pending·0 cites
- 2853US2008119488A1Modulators Of Nuclear ReceptorsEXELIXIS INC·Filed 2005·Application pending·0 cites
- 2953US2024301369A1Polynucleotide and expression cassette comprising coding sequence of toluene dioxygenase, and use thereofSHANGHAI SHENGPING MEDICAL EQUIPMENT CO LTD·Filed 2022·Application pending·0 cites
- 3051US8163771B211 β-HSD1 modulatorsMARTIN RICHARD·Filed 2009·Granted Apr 24, 2012·0 cites·40 claims
- 3149US2009247559A1BenzofuropyrimidinonesEXELIXIS INC·Filed 2008·Application pending·0 cites
- 3248US2022288187A1Biodegradable nanocomplex vaccines, methods for suppression of hepapitis b virus replication and hepapitis b virus surface antigen secretionLEE FRANK WEN CHI·Filed 2020·Application pending·0 cites
- 3348US2004138255A1Phosphate mimics and methods of treatment using phosphatease inhibitorsSUGEN INC·Filed 2003·Application pending·0 cites
- 3447US2024052003A1Compositions comprising pedf-derived short peptides (pdsp) and uses thereofBRIM BIOTECHNOLOGY INC·Filed 2020·Application pending·0 cites
- 3546US7122548B2Triazolotriazine compounds and uses thereofSUGEN INC·Filed 2004·Granted Oct 17, 2006·0 cites·13 claims
- 3646US5334537ADirect immunoassay using pH-sensitive fluorochromesUNIV MARYLAND·Filed 1991·Granted Aug 2, 1994·13 cites·7 claims
- 3746US2023330222A1Selective targeting of the treml1/md2 interaction by small peptide or protein and its use for vaccine adjuvantsASCENDO BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3846US2017342169A1Bispecific binding proteinsABBVIE BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3944US2021324084A1Method for suppression of hepapitis b virus replication and hepapitis b virus surface antigen secretionASCENDO BIOTECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 4043US2020255531A1Method for modulation of tumor associated myeloid cells and enhancing immune checkpoint blockadeMACKAY MEMORIAL HOSPITAL·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ping Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →